Tailored Individual Follow-Ups Versus a One-Day Group Course in Patients With Long COVID Post– COVID-19 Condition: Protocol for a Randomized Controlled Trial
BACKGROUND
The high prevalence of patients with post COVID -19 condition, also called long COVID, even among those with mild initial disease, may have a large impact on both the individual and society. Disability in everyday life, reduced health-related quality of life and work capacity, strain on the healthcare system and substantial socioeconomic costs are associated with long COVID. More research to investigate the effectiveness of rehabilitation services is warranted.
OBJECTIVE
The purpose of this study is to examine the effectiveness of tailored individual follow-ups versus a one-day group course in patients with long COVID. Additionally, the feasibility and utility of a mobile application for self-monitoring goal achievement will be assessed.
METHODS
This is a single-center, parallel-group, superiority randomized controlled trial with a 1:1 allocation ratio. A total of 62 outpatients aged 18–65 years with long COVID will be randomized to either a rehabilitation program with individual follow-up consultations or a one-day self-management group course. The individual intervention incorporates setting goals, teaching cognitive-behavioral strategies, energy management (pacing), and a supervised gradual increase in both physical and cognitive activities tailored to individual tolerance levels. The primary outcome is the between-group difference in health-related quality of life, measured using the EQ-5D-5L-index at 6 months. Secondary outcomes include improvements in symptoms, work participation, neurocognitive function, and app usability, assessed at 3-, 6-, and 12 months depending on the outcome measure.
RESULTS
Data enrolment started in October 2023. A total of 62 participants were included by November 2024. Data collection is planned to be completed in November 2025.
CONCLUSIONS
Long COVID poses significant challenges for both individuals and society, underscoring the need for effective rehabilitation strategies. This study will provide valuable insights into the benefits of an individualized outpatient rehabilitation program. The results from this clinical trial will help guide future treatment recommendations and may improve long-term outcomes for affected patients. Additionally, the study will generate important knowledge about neuropsychological function and digital self-management tools in long COVID rehabilitation. Clinical Trial: ClinicalTrials.gov NCT06085911; https://www.clinicaltrials.gov/study/NCT06085911
Web | DOI | PDF | JMIR Research Protocols | Open Access
BACKGROUND
The high prevalence of patients with post COVID -19 condition, also called long COVID, even among those with mild initial disease, may have a large impact on both the individual and society. Disability in everyday life, reduced health-related quality of life and work capacity, strain on the healthcare system and substantial socioeconomic costs are associated with long COVID. More research to investigate the effectiveness of rehabilitation services is warranted.
OBJECTIVE
The purpose of this study is to examine the effectiveness of tailored individual follow-ups versus a one-day group course in patients with long COVID. Additionally, the feasibility and utility of a mobile application for self-monitoring goal achievement will be assessed.
METHODS
This is a single-center, parallel-group, superiority randomized controlled trial with a 1:1 allocation ratio. A total of 62 outpatients aged 18–65 years with long COVID will be randomized to either a rehabilitation program with individual follow-up consultations or a one-day self-management group course. The individual intervention incorporates setting goals, teaching cognitive-behavioral strategies, energy management (pacing), and a supervised gradual increase in both physical and cognitive activities tailored to individual tolerance levels. The primary outcome is the between-group difference in health-related quality of life, measured using the EQ-5D-5L-index at 6 months. Secondary outcomes include improvements in symptoms, work participation, neurocognitive function, and app usability, assessed at 3-, 6-, and 12 months depending on the outcome measure.
RESULTS
Data enrolment started in October 2023. A total of 62 participants were included by November 2024. Data collection is planned to be completed in November 2025.
CONCLUSIONS
Long COVID poses significant challenges for both individuals and society, underscoring the need for effective rehabilitation strategies. This study will provide valuable insights into the benefits of an individualized outpatient rehabilitation program. The results from this clinical trial will help guide future treatment recommendations and may improve long-term outcomes for affected patients. Additionally, the study will generate important knowledge about neuropsychological function and digital self-management tools in long COVID rehabilitation. Clinical Trial: ClinicalTrials.gov NCT06085911; https://www.clinicaltrials.gov/study/NCT06085911
Web | DOI | PDF | JMIR Research Protocols | Open Access